<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A serine protease activated protein C has been shown to be a powerful neuroprotectant in stressed neurons and in hypoxic brain endothelium </plain></SENT>
<SENT sid="1" pm="."><plain>In a clinically relevant model of embolic <z:hpo ids='HP_0001297'>stroke</z:hpo> in rodents, we now show that administration of activated protein C alone or in combination with tissue plasminogen activator, or both, 4 hours after embolic <z:hpo ids='HP_0001297'>stroke</z:hpo> improves the functional outcome and reduces <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> within 7 days of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In contrast, tissue plasminogen activator alone was not protective </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, activated protein C may be useful as a new stand-alone therapy for clinical <z:hpo ids='HP_0001297'>stroke</z:hpo> and to extend the time window of thrombolytic therapy </plain></SENT>
</text></document>